KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Snap-on (SNA) Cash & Equivalents (2016 - 2026)

Snap-on has reported Cash & Equivalents over the past 18 years, most recently at $1.8 billion for Q2 2026.

  • Quarterly Cash & Equivalents rose 22.19% to $1.8 billion in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Apr 2026, up 22.19% year-over-year, with the annual reading at $1.6 billion for FY2026, 19.4% up from the prior year.
  • Cash & Equivalents was $1.8 billion for Q2 2026 at Snap-on, up from $1.6 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $1.8 billion in Q2 2026 and troughed at $757.2 million in Q4 2022.
  • The 5-year median for Cash & Equivalents is $1.1 billion (2023), against an average of $1.1 billion.
  • Biggest five-year swings in Cash & Equivalents: fell 15.84% in 2022 and later soared 41.48% in 2024.
  • Tracing SNA's Cash & Equivalents over 5 years: stood at $757.2 million in 2022, then surged by 32.26% to $1.0 billion in 2023, then surged by 35.85% to $1.4 billion in 2024, then grew by 12.76% to $1.5 billion in 2025, then grew by 14.29% to $1.8 billion in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $1.8 billion, $1.6 billion, and $1.5 billion for Q2 2026, Q1 2026, and Q3 2025 respectively.